Skip to main content

Peer Review reports

From: BRCA1/2 variants and copy number alterations status in non familial triple negative breast cancer and high grade serous ovarian cancer

Original Submission
27 Dec 2021 Submitted Original manuscript
29 Jan 2022 Author responded Author comments - Fatima Zahra El Ansari
Resubmission - Version 2
29 Jan 2022 Submitted Manuscript version 2
18 Mar 2022 Reviewed Reviewer Report - Helena Rudnicka
24 Mar 2022 Reviewed Reviewer Report - Tianhui Chen
27 Apr 2022 Author responded Author comments - Fatima Zahra El Ansari
Resubmission - Version 3
27 Apr 2022 Submitted Manuscript version 3
11 May 2022 Reviewed Reviewer Report - Tianhui Chen
30 May 2022 Reviewed Reviewer Report - Helena Rudnicka
11 Jun 2022 Author responded Author comments - Fatima Zahra El Ansari
Resubmission - Version 4
11 Jun 2022 Submitted Manuscript version 4
29 Jun 2022 Reviewed Reviewer Report - Helena Rudnicka
5 Jul 2022 Reviewed Reviewer Report - Tianhui Chen
8 Aug 2022 Author responded Author comments - Fatima Zahra El Ansari
Resubmission - Version 5
8 Aug 2022 Submitted Manuscript version 5
Publishing
9 Aug 2022 Editorially accepted
19 Aug 2022 Article published 10.1186/s13053-022-00236-y

You can find further information about peer review here.

Back to article page